List of Genelabs Technologies patents

Patents where

Current Assignee

Name

Genelabs Technologies

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 6849713 Compounds possessing antibacterial, antifungal or antitumor activity	Patent 6849713 was granted and assigned to Genelabs Technologies on February, 2005 by the United States Patent and Trademark Office.	Genelabs Technologies	United States Patent and Trademark Office	6849713	February 1, 2005
‌ US Patent 6906103 Compounds possessing antibacterial, antifungal or antitumor activity	Patent 6906103 was granted and assigned to Genelabs Technologies on June, 2005 by the United States Patent and Trademark Office.	Genelabs Technologies	United States Patent and Trademark Office	6906103	June 14, 2005
‌ US Patent 7064218 Aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity	Patent 7064218 was granted and assigned to Genelabs Technologies on June, 2006 by the United States Patent and Trademark Office.	Genelabs Technologies	United States Patent and Trademark Office	7064218	June 20, 2006
‌ US Patent 7094768 Nucleoside derivatives for treating hepatitis C virus infection	Patent 7094768 was granted and assigned to Genelabs Technologies on August, 2006 by the United States Patent and Trademark Office.	Genelabs Technologies	United States Patent and Trademark Office	7094768	August 22, 2006
‌ US Patent 7511145 Bicyclic heteroaryl derivatives	Patent 7511145 was granted and assigned to Genelabs Technologies on March, 2009 by the United States Patent and Trademark Office.	Genelabs Technologies	United States Patent and Trademark Office	7511145	March 31, 2009
‌ US Patent 6951880 Aryl and heteroaryl compounds as antibacterial and antifungal agents	Patent 6951880 was granted and assigned to Genelabs Technologies on October, 2005 by the United States Patent and Trademark Office.	Genelabs Technologies	United States Patent and Trademark Office	6951880	October 4, 2005
‌ US Patent 7425547 Nucleoside derivatives for treating hepatitis C virus infection	Patent 7425547 was granted and assigned to Genelabs Technologies on September, 2008 by the United States Patent and Trademark Office.	Genelabs Technologies	United States Patent and Trademark Office	7425547	September 16, 2008
‌ US Patent 7144868 Nucleoside compounds for treating viral infections	Patent 7144868 was granted and assigned to Genelabs Technologies on December, 2006 by the United States Patent and Trademark Office.	Genelabs Technologies	United States Patent and Trademark Office	7144868	December 5, 2006
‌ US Patent 7432248 Nucleoside derivatives for treating Hepatitis C virus infection	Patent 7432248 was granted and assigned to Genelabs Technologies on October, 2008 by the United States Patent and Trademark Office.	Genelabs Technologies	United States Patent and Trademark Office	7432248	October 7, 2008
‌ US Patent 7157434 Nucleoside compounds for treating viral infections	Patent 7157434 was granted and assigned to Genelabs Technologies on January, 2007 by the United States Patent and Trademark Office.	Genelabs Technologies	United States Patent and Trademark Office	7157434	January 2, 2007
‌ US Patent 7244713 Nucleoside compounds for treating viral infections	Patent 7244713 was granted and assigned to Genelabs Technologies on July, 2007 by the United States Patent and Trademark Office.	Genelabs Technologies	United States Patent and Trademark Office	7244713	July 17, 2007
‌ US Patent 7414031 5-nitro-nucleoside compounds for treating viral infections	Patent 7414031 was granted and assigned to Genelabs Technologies on August, 2008 by the United States Patent and Trademark Office.	Genelabs Technologies	United States Patent and Trademark Office	7414031	August 19, 2008
‌ US Patent 7189506 DNA binding compound-mediated molecular switch system	Patent 7189506 was granted and assigned to Genelabs Technologies on March, 2007 by the United States Patent and Trademark Office.	Genelabs Technologies	United States Patent and Trademark Office	7189506	March 13, 2007
‌ US Patent 7405204 Nucleoside compounds for treating viral infections	Patent 7405204 was granted and assigned to Genelabs Technologies on July, 2008 by the United States Patent and Trademark Office.	Genelabs Technologies	United States Patent and Trademark Office	7405204	July 29, 2008
‌ US Patent 7141680 Aromatic compounds possessing antifungal or antibacterial activity	Patent 7141680 was granted and assigned to Genelabs Technologies on November, 2006 by the United States Patent and Trademark Office.	Genelabs Technologies	United States Patent and Trademark Office	7141680	November 28, 2006
‌ US Patent 7169918 Methods for preparing 7-(2′-substituted-β-D-ribofuranosyl)-4-(NR	Patent 7169918 was granted and assigned to Genelabs Technologies on January, 2007 by the United States Patent and Trademark Office.	Genelabs Technologies	United States Patent and Trademark Office	7169918	January 30, 2007
‌ US Patent 7202223 Nucleoside compounds for treating viral infections	Patent 7202223 was granted and assigned to Genelabs Technologies on April, 2007 by the United States Patent and Trademark Office.	Genelabs Technologies	United States Patent and Trademark Office	7202223	April 10, 2007
‌ US Patent 7304085 Nitrogen-containing heteroaryl derivatives	Patent 7304085 was granted and assigned to Genelabs Technologies on December, 2007 by the United States Patent and Trademark Office.	Genelabs Technologies	United States Patent and Trademark Office	7304085	December 4, 2007
‌ US Patent 7151089 Nucleoside compounds for treating viral infections	Patent 7151089 was granted and assigned to Genelabs Technologies on December, 2006 by the United States Patent and Trademark Office.	Genelabs Technologies	United States Patent and Trademark Office	7151089	December 19, 2006
‌ US Patent 6838556 Promoters for regulated gene expression	Patent 6838556 was granted and assigned to Genelabs Technologies on January, 2005 by the United States Patent and Trademark Office.	Genelabs Technologies	United States Patent and Trademark Office	6838556	January 4, 2005
‌ US Patent 6854468 Treatment of subnormal bone mineral density	Patent 6854468 was granted and assigned to Genelabs Technologies on February, 2005 by the United States Patent and Trademark Office.	Genelabs Technologies	United States Patent and Trademark Office	6854468	February 15, 2005
‌ US Patent 7045513 DHEA composition and method	Patent 7045513 was granted and assigned to Genelabs Technologies on May, 2006 by the United States Patent and Trademark Office.	Genelabs Technologies	United States Patent and Trademark Office	7045513	May 16, 2006
‌ US Patent 6869765 Sequence-directed DNA-binding molecules compositions and methods	Patent 6869765 was granted and assigned to Genelabs Technologies on March, 2005 by the United States Patent and Trademark Office.	Genelabs Technologies	United States Patent and Trademark Office	6869765	March 22, 2005

23 results

0 selected

23 results

0 selected